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Functional coatingA bioactive glass topcoat was introduced tomodify the surfacemorphology and in-vitro reactivity of hydroxyap-
atite (HA) coatings for biomedical applications.With this aim, a CaO-rich bioactive glass, termed BG_Ca (wt.%: 4.7
Na2O, 42.3 CaO, 6.1 P2O5, and 46.9 SiO2), was selected due to its goodbioactivity and low tendency to crystallize at
high temperature. The standardHA coatingswere sprayed through atmospheric plasma spray (APS) on steel sub-
strates starting from commercial powders (“APS-HA” samples). The HA coatings, in turn, were subsequently
coated with a thin layer of bioactive glass by suspension plasma spray (SPS), thus obtaining the duplex systems
(“APS-HA/SPS-BG_Ca” samples). The sampleswith andwithout the BG_Ca layerwere analysed bymicrostructur-
al characterization and by in vitro tests in simulated body ﬂuid (SBF). The analysis revealed an increased reactiv-
ity of the APS-HA/SPS-BG_Ca samples compared to the glass-free APS-HA coatings.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Over the last decades, biomedical sciences have acquired a growing
importance. In particular, the progressive ageing of population and
diffusion of morbid obesity, with related musculoskeletal disorders,
are driving the development of innovative materials for bone implants
[1]. Though the production of biomedical devices is nowadays a mature
and well-established practice, the research is constantly evolving
with the aim of improving the reliability and effectiveness of the
available prostheses, thus increasing their life expectancy in service
conditions [2].
Hydroxyapatite, HA (Ca10(PO4)6(OH)2), is a calcium phosphate
ceramic whose composition and structure are very similar to those of
the mineral component of bone. It is therefore osteoconductive, with
an excellent biocompatibility which allows bone cells to grow on its
surface [3]. For this reason, HA is currently applied in orthopaedics
and dentistry with very encouraging results [4]. Unfortunately HA is
brittle and hence it is not suitable for structural applications. A way to
overcome this problem is to use HA as a coating on a metal implant,
which would provide the required mechanical strength. Nowadays,
the plasma spraying is the standard method to produce HA coatings
[5,6]. In fact, this method makes it possible to achieve a high deposition
rate, which results in high coating production rate; moreover plasma
sprayed HA coatings, in turn, may reach a suitable adhesion to the sub-
strate [7]. Although the plasma spray process has been thoroughly stud-
ied and optimized in recent years, some isolated cases of implant failure
are still reported and revision surgeries are sometimes necessary [8].g “Enzo Ferrari”, University of
dena (MO), Italy.
ghts reserved.Moreover the host tissue-HA bonding reactions begin after several
hours after implantation, and therefore HA coatings are not the opti-
mumsolution if a fast ﬁxation is required [4,9]. Consequently, numerous
studies address the development of new bioactive coatings [10–12].
Similarly, much research has been performed on both alternative mate-
rials and innovative deposition techniques [13–16]. An example of an
emerging family of biomedical materials is given by bioactive glasses.
They are particularly interesting, because they possess the highest
degree of bioactivity controlled by their chemical composition [17]. In
particular, 45S5Bioglass® (in wt.%: 24.5 Na2O, 24.5 CaO, 6 P2O5, 45
SiO2) is the most representative glass of the so-called “Bioglass” family,
ﬁrst proposed by Prof. Hench at the end of the 1960s [18]. Due to their
particular composition, bioglasses possess a strong bone-bonding abili-
ty; speciﬁc formulations are even able to connect to soft tissues [19].
Unfortunately, conventional bioglasses are likely to devitrify at high
temperature and the development of crystalline phases is known to re-
tard the original bioactivity [20]. Some new experimental compositions
are about to emerge aiming at limiting the tendency to crystallize i.e.
preserving the amorphous structure of the glass during high-
temperature processes, such as sintering and thermal spray coating de-
position [21,22]. A new strategy to obtain improved bioactive coatings
may lead to the improvement of the deposition process. Indeed, even
if plasma spraying is the most widely used technique to produce bio-
medical coatings, many innovations have been recently proposed,
such as suspension plasma spraying (SPS) [23]. In this process, the feed-
stock is a liquid suspension of ﬁne, nanometric ormicrometric solids in-
stead of the usual dry powder having micrometric size. This is a key
point, since the dispersion of a solid powder in a liquid medium
(water or organic solvent) makes it possible to process very ﬁne parti-
cles or hygroscopic materials (such as bioactive glasses), which
Fig. 1. Coatings' deposition process: (a) SPS set-up, (b) production scheme of the coatings.
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cause of their poor ﬂowability. As a result of spraying process, a con-
trolled microstructure, with very small (near-nanometric) intralamellar
crystalline grains, can be obtained [24].
In the present study, a bioactive glass topcoat was applied by the in-
novative SPS technique on a conventional HA plasma sprayed coating.
The BG_Ca glass (having composition, in wt.%: 4.7 Na2O, 42.3 CaO, 6.1
P2O5, and 46.9 SiO2) was selected since it combines high bioactivity
with a relatively low tendency to crystallize at high temperature [25,26].
The aim of such functional duplex system was to merge the HA's
biocompatibility and long term stability, which are useful to protect
the metal substrate from the physiological environment, with the high
bioactivity of the SPS bioactive glass top-coat.
In order to assess the effectiveness of the bioactive glass topcoat to
accelerate the mineralization process in a physiological environment,
the samples with and without a BG_Ca layer were tested in vitro, by
soaking them in a simulated body ﬂuid (SBF) [27].
2. Materials and methods
2.1. Feedstock materials
The hydroxyapatite (HA) powder was a commercial product
manufactured by Tomita (Japan). The powder had a mean diameter
of d50 = 120 μm, but it consisted of spray dried sub-micrometric
particles having internal porosity of about 12% [28].
As described in a previous contribution [28], the bioactive glass
(BG_Ca) [25,26] was produced by the conventional melt-quenching
method. Appropriate raw materials were mixed and then molten in a
platinum crucible at 1450 °C. The molten glass was poured into water.
The obtained frit was dried overnight at 110 °C and dry milled in an
agate mortar and sieved at 63 μm. The powder was further milled in
an attrition system by using 0.8 mm zirconia balls and adding the
dispersant Beycostat C213 (2 wt.% of the dry powder). Since bioactive
glass powders are water-reactive [29], ethanol was selected as the
suspension liquid. The obtained BG_Ca powder had a monomodal
distribution with a mean diameter of d50 = 4.7 μm (determined with
a granulometer Partica LA-950V2, Horiba). The feedstock suspension
was formulated by dispersing 20 wt.% of solid phase in 80 wt.% of
ethanol.
2.2. Coatings' deposition
Plasmaspray runs were performed using a SG-100 torch (Praxair,
S.T., Indianapolis, IN, USA). Substrates were 316L stainless steel disks
(diameter: 25 mm; thickness: 8 mm), preliminary sandblasted to
a roughness Ra = 4.3 μm (determined by means of Tester T500,
Hommel) and ultrasonically cleaned with ethanol and acetone. 316L
steel was chosen because it has proved to be acceptable for orthopaedic
implants over decades of use and currently it is widely diffused for
fracture repair devices [30].
During the APS deposition, the HApowderwas supplied by a labora-
tory powder feeder including an Ar-pressurized chamber and a vibrat-
ing system.
To deposit the BG_Ca topcoat, a pneumatic system was used to feed
the suspension (Fig. 1a); to avoid agglomeration and sedimentation, the
suspension was continuously agitated by a magnetic stirrer. Both feed-
stock materials were (separately) supplied into the plasma by internal
injection. The injection oriﬁcewas radial inside the anode andmounted
at 16 mm from torch's exit. A schematic representation of the SPS
deposition process is shown in Fig. 1b.
Several deposition attemptswere carried out using tentative param-
eters taken from the literature [28,31]. Then, based on the preliminary
trials, the ﬁnal spray parameters were deﬁned, with the aim of optimiz-
ing the density and the thickness of the APS-HA layer and, at the same
time, promoting the bioactivity of the glass topcoat, which shouldremain amorphous and properly porous. The deposition parameters
set for the two powders are speciﬁed in Table 1.
During the spraying sessions, the temperature of the coatings' sur-
face was measured using an optical IN 5 Plus pyrometer (Impac).
2.3. In vitro tests
In order to investigate the effect of the glass topcoat on the reactivity
in physiological ﬂuids, both the APS-HA samples and the APS-HA/
SPS-BG_Ca sampleswere soaked in a simulated bodyﬂuid (SBF) accord-
ing to the standard procedure proposed by Kokubo [27]. The SBF was
refreshed every 2 days to mimic the dynamic conditions of the human
body. The samples were removed from the SBF after time periods of 1,
3, 7, and 14 days. The samples were washed with distilled water and
left to dry at room temperature before further characterization.
Table 1
Deposition parameters used to apply the pure HA coating by plasma spraying (APS-HA)
and the bioactive glass topcoat by suspension plasma spraying (SPS-BG_Ca).
APS-HA SPS-BG_Ca
Torch power [kW]: 21 40
Gases
Ar [slpm]: 48 45
H2 [slpm]: 2 7.5
Spray distance [mm]: 100 70
Torch speed [mm/s]: 500 750
Scan step [mm]: 10 10
Feedstock ﬂow rate [g/min]: 10 30
Injector diameter [mm]: 1 0.3
Carrier gas ﬂow rate [slpm]: Ar, 3 –
Static pressure [MPa]: – 0.17
Number of torch passes: 36 2 × 4 runs
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The sampleswere analysed before and after soaking in SBF by differ-
ent techniques.
The surface of the coatings was investigated by X-ray diffraction,
XRD, with an X'pert PRO diffractometer (PANalytical, Almelo, The
Netherlands) equipped with the X'Celerator detector, and employing
Cu-Kα radiation. Diffraction patterns were collected in the 10°–70° 2θ
range (step size: 0.017°, step time: 71.12 s).
An accuratemicrostructural analysis was carried out on the coatings'
surfaces and polished cross sections by means of an environmentalFig. 2. Substrate temperature measured during spray sessions: (a) atmospheric plascanning electron microscope, ESEM (ESEM Quanta 200-FEI Company,
Eindhoven, The Netherlands) coupledwith an X-EDSmicroanalysis sys-
tem (Inca, Oxford Instruments, U.K.). The microscope was operated
both in high-vacuum and low-vacuum modes (pressure: 60 Pa).
The coatings' surface was analysed by micro-Raman spectroscopy
(Jobin-Yvon Raman Microscope Spectrometer, HORIBA Jobin Yvon
S.A.S., Villeneuve d'Ascq, France). The laser source emits 20 mW at
632.8 nm; 100× objective and no ﬁlters were employed.
3. Results and discussion
During the deposition of the APS-HA layer, the surface temperature
did not exceed 250 °C and, at the end of the process, the temperature
was about 200 °C (Fig. 2). During deposition of the SPS-BG_Ca topcoat,
the temperature was slightly higher, with an average value of about
250 °C and local peaks of 330 °C. However such values are relatively
lowwith respect to those usually achieved in SPS deposition with etha-
nol [28]. In fact, the ﬁnal parameters (listed in Table 1) were purposely
deﬁned to avoid an excessive heatﬂux to the coating in order to prevent
the glass from crystallizing. This also limited the sintering process and
therefore it resulted in a porous glass topcoat, which is expected to
enhance its bioactivity [28]. To reduce the heat ﬂux to the sample, the
spraying distance was set to 70 mm and the glass topcoat was sprayed
in four discontinued spray runs, with two torch passes for each run.
Moreover, in order to control the surface temperature, the samples
were cooled down to the temperature below 70 °C before starting
each runs (Fig. 2b).sma spray deposition of HA, (b) suspension plasma spray deposition of BG_Ca.
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preserved its phase composition after the deposition. In fact, the spec-
trumof theAPS-HAcoating is similar to that of the original HA feedstock
powder. However some secondary phases could be also detected,which
resulted from a partial decomposition of the HA. In particular, the peaks
in the 29°–31° 2θ range could be associated to the formation of tri-
calcium phosphate, TCP, and tetra-calcium phosphate, TTCP. The peak
at 2θ = 37.5° corresponded to CaO. Since the relative amounts of the
decomposition phases in HA coatings may be linked to the relative in-
tensity of the corresponding peaks in XRD patterns [32], it is likely
that the thermal decomposition of the APS-HA coatings was very limit-
ed, since the peaks associated to the secondary phases were relatively
weak. The limited decomposition of HA could have been favoured by
the relatively low temperature of particles in-ﬂight in the plasma jet,
resulting from the low enthalpy of the plasma gas. Indeed, it is known
from the literature that HA is prone to decompose [33], since it loses
its OH− groups (de-hydroxylation) at high temperature, with a two-
step process resulting ﬁrst in the formation of oxyhydroxyapatite and
then of oxyapatite [34]. If the temperature does not exceed a critical
point, these new phases can return into HA phase in the presence of
water [35]. Otherwise, if the critical temperature is surpassed, the HA
crystal structure changes and suffers a complete and irreversible dehy-
droxylation [36]. If the temperature increases further, HA starts to
decompose to other calcium phosphates, such as TCP and TTCP. These
phases, in turn, can degrade into calciumoxide and phosphorus pentox-
ide [34,36]. Even if the thermal decomposition is affected by several
circumstances, such as the environment [37] and the initial purity and
degree of crystallinity of HA [38,39], the critical point beyond which
the decomposition is irreversible is about 1350 °C [36].
Fig. 3 also shows that, in the diffraction spectrum of the APS-HA/
SPS-BG_Ca sample, a broad band between 25° and 35° (2θ) was present,
as often observed in silicate glasses. In addition, some new weak peaks
could be detected, which may be associated with a calcium silicate,
Ca2SiO4 (larnite). It is interesting to note that in the relatively Na2O-
poor BG_Ca glass a calcium silicate, instead of a sodium-calcium silicate
developed, which is the typical outcome of the crystallization of 45S5
Bioglass® and other Na2O-rich bioglasses [26]. Moreover, well-deﬁned
peaks could be attributed to the HA layer underneath the glass topcoat.
The partial transparency of the topcoat to the X-rays resulted from the
intrinsic properties of silicate glasses, as previously observed for other
silicate-based bioactive glass coatings [40], and from the structure ofFig. 3. Comparison between the X-ray diffraction pattern of the commercial HA feedstock
powder and those of the coatings. Symbols: *, larnite (Ca2SiO4, 01-070-0388); ▲, TTCP
(00-025-1137);▼, TCP (00-009-0169);■, CaO (01-075-0264); the peaks without symbol
are due to HA (01-089-6437).the topcoat itself, which was highly porous and relatively thin, as con-
ﬁrmed by the ESEM inspection described below.
The microstructure of the APS-HA samples was compact, with rela-
tively low porosity, as shown in Fig. 4a. Some dark areas could be ob-
served in the cross section. Since the EDS analysis (Fig. 5) conﬁrmed
that they were composed of HA, with atomic proportions analogous to
those of the surrounding light-grey material, it is possible that such
dark areaswere the cross sections of unmeltedHAparticles incorporated
into the coating. In fact, depending on the deposition conditions, partially
molten or completely unmelted particles may remain in HA coatings
produced by thermal spray techniques [41]. The surface of the APS-HA
coatings (Fig. 4b) displayed both large splats, with diameters measuring
some tens of microns, and areas with ﬁner grains.
The inspection of the cross section of the APS-HA/SPS-BG_Ca sam-
ples conﬁrmed that the glass topcoat was relatively thin, with typical
thickness of about 20 μm (Fig. 6a). Most of all, the glass layer was
characterised by a very ﬁne microstructure, which is a distinctive fea-
ture of SPS coatings [23]. Moreover the BG_Ca topcoat wasmore porous
than the atmospheric plasma sprayed HA layer. The rich porosity that
characterises the glass topcoat is expected to enhance the implant
osteointegration in vivo, since it confers a “trabecular-like” structure
to the coating [42]. With regard to the surface morphology, the glass
topcoat was extremely rough, as shown in Fig. 6b. A high roughness
may be extremely advantageous, since it increases the speciﬁc surface
area available for chemical reactions and hence favours the cell attach-
ment [43]. Moreover, the surface roughness and morphology have
signiﬁcant impact on protein adsorption [44]. To conclude, very ﬁne
needle-like structures could be observed on the surface of the APS-
HA/SPS-BG_Ca coatings. It is possible that the structure results from
the crystals of the Ca2SiO4 phase identiﬁed by the XRD.
After the immersion in SBF, the surface of both types of coatings
(with and without the glass topcoat) was covered by dome-like struc-
tures which are typical of hydroxy-carbonate-apatite (HCA) depositsFig. 4. APS-HA coatings: (a) cross section, (b) surface.
Fig. 5. Details of the APS-HA cross section and corresponding EDS microanalyses.
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types of samples (Fig. 7) suggests that the APS-HA/SPS-BG_Ca system
reacted more rapidly than the APS-HA one. Indeed, the surface of the
glass topcoat quickly assumed a more globular morphology. Moreover
it is interesting to note that the ﬁne crystalline structures originally
present on the APS-HA/SPS-BG_Ca sample completely disappeared
already after 1 day in SBF.
Fig. 8 propose some representative images of the cross section of the
samples soaked in SBF. After one day, a fewmicron-thick reaction layer
grew on the APS-HA coating (Fig. 8a); as shown by the X-EDS analysis
(Table 2), such layer had a Ca/P ratio of 1.49, a value observed already
in calcium-deﬁcient amorphous calcium phosphate (ACP) [47].
Instead, if the APS-HA/SPS-BG_Ca system is considered (Fig. 8b),
after one day in SBF the glass topcoat underwent a through-thicknessFig. 6. APS-HA/SPS-BG_Ca coatings:(a) cross section; (b) surface.reaction and only silicon and oxygen could be detected by the X-EDS
analysis (Table 2), thus suggesting a silica gel layer developed on the
surface. The very high reactivity of the topcoat was due to the con-
comitant effect of the intrinsic bioactivity of the BG_Ca glass [26]
and of the porousmicrostructure of the layer. In fact the rich porosity
of the topcoat favoured the penetration of SBF in depth and greatly
increased the speciﬁc surface area available for the chemical reac-
tions. Moreover it was observed that, already after one day in SBF,
the silica gel layer, in turn, was covered by a very thin deposit of cal-
cium phosphate. The progressive conversion of the original glass to
silica gel and the subsequent growth of the hydroxy-carbonate apa-
tite (HCA) surface layer detected on the APS-HA/SPS-BG_Ca system
are similar to the mineralization reactions occurring on conventional
bioactive glasses in bulk form [48]. The growth of the calcium phos-
phate layer on the APS-HA/SPS-BG_Ca sample continued for increasing
immersion time and, after one week in SBF, the original glass topcoat
has disappeared, since it was completely converted to HCA (Fig. 8c)
with a Ca/P ratio close to that of stoichiometric HA, i.e. Ca/P ~1.67 [3]
(Table 2). It is interesting to note that the HCA precipitates were per-
fectly integrated into the coating, since the interface was not easily
detectable.
As a general consideration, according to the SEMoutcomes, the reac-
tion kinetics proceeded faster on the APS-HA/SPS-BG_Ca system than
on the pure APS-HA coating. In fact, the HCA layer grown on the APS-
HA sample after 14 days in SBF was thinner than that grown on the
APS-HA/SPS-BG_Ca system after 7 days in SBF, as apparent from the
comparison of the corresponding SEM images in Fig. 8d and c.
The XRD pattern of the APS-HA sample reported in Fig. 9 (bold
traces) did not show sensible variations as a result of the immersion
in SBF. However, starting from the ﬁrst day of immersion, the peaks as-
sociated to the secondary phases (TCP, TTCP and CaO) gradually disap-
peared. More precisely, the peak associated to CaO vanished already
after one day of immersion, whereas the peaks of TTCP and TCP were
not visible after seven days. On the other hand, the peaks of HA did
not vary with increasing immersion time.
In contrast to this, the XRD patterns of the APS-HA/SPS-BG_Ca
samples (Fig. 9, thin traces) strongly changed after immersion in
SBF. Starting from the ﬁrst day, the main peaks of HCA could be iden-
tiﬁed, although they were very broad. The large width of the peaks
was indicative of the poor crystallinity of HCA, an effect that is
often observed for in vitro grown HCA [49]. At the same time, the
peaks due to Ca2SiO4 disappeared, supporting the hypothesis that
such crystallizations were mainly constituted by superﬁcial ﬁne
crystals, readily dissolved by the SBF. The peak at 2θ = 29.4°, ob-
served occasionally in the XRD spectra of the soaked samples, is
due to CaCO3, a mineral that may co-precipitate in vitro with HCA
[27,50].
Fig. 7. Surface morphology after in vitro tests: APS-HA samples (a, b, c, d); APS-HA/SPS-BG_Ca samples (d, e, f, g). The scale bar is the same for all images, secondary electrons.
115A. Cattini et al. / Surface & Coatings Technology 240 (2014) 110–117Further information on the reactions occurring in SBF was obtained
by means of Raman micro-spectroscopy. Fig. 10 compares the spectra
of the APS-HA samples (bold traces) and those of the APS-HA/
SPS-BG_Ca ones (thin traces). In particular, if the pattern of the
as-sprayed APS-HA coating is considered, the peak associated to
the symmetrical stretching of the PO4 group, at about 960 cm−1,
can be separated in two different contributions, namely a broad and
weak peak, and a sharp and intense one. The latter can be associated
to HA, while the former is thought to be due to the decompositionFig. 8. Cross section of the coatings after immersion in SBF: (a) APS-HA coating after 1 day in SB
7 days in SBF; (d) APS-HA coating after 14 days in SBF.phases: ACP, TTCP and TCP [51]. After immersion in SBF (Fig. 10, bold
traces), the Raman peaks associated with HA became broader and less
deﬁned, but they did not shift to different wavenumbers. The gradual
change in the peak shape was likely due to the precipitation of poorly
crystallized HCA on the original surface.
The Raman spectra acquired on the surface of the APS-HA/
SPS-BG_Ca coatings showed a marked change after the immersion in
SBF (Fig. 10, thin traces). In the spectrum of the as-sprayed coating,
three bands related to the BG_Ca glass were observed: a ﬁrst band atF; (b) APS-HA/SPS-BG_Ca coating after 1 day in SBF; (c) APS-HA/SPS-BG_Ca coating after
Table 2
Coatings' composition evaluated by X-EDS analysis performed on the cross-section of SBF
soaked samples (Fig. 8).
Point Ca P Si O Ca/P
APS-HA, 1 day in SBF (Fig. 8a) 1 24.38 15.05 – 60.57 1.62
2 22.95 15.46 – 61.59 1.49
3 22.58 15.86 – 61.56 1.49
APS-HA/SPS-BG, 1 day in SBF (Fig. 8b) 1 49.53 0.27 – 50.20 –
2 – – 33.33 66.67 –
APS-HA/SPS-BG, 7 days in SBF (Fig. 8c) 1 24.48 14.53 – 60.89 1.68
2 23.15 15.37 – 61.48 1.51
APS-HA, 14 days in SBF (Fig. 8d) 1 23.04 15.41 – 61.56 1.50
2 22.36 15.80 – 61.85 1.42
116 A. Cattini et al. / Surface & Coatings Technology 240 (2014) 110–117about 635 cm−1 and a second one in the range from 800 to 1150 cm−1,
which are both associated to the Si\O\Si bonds in silica, and a third
band at 950 cm−1, which is due to the symmetrical stretching of the
PO4 group [52]. Then, after soaking in SBF, the new peaks of the precip-
itated HCA progressively replaced the signals of the original glass and
they steadily became sharper with increasing immersion time. From
this point of view, the evolution of the Raman spectra of the APS-HA/
SPS-BG_Ca samples in SBF corresponded to that of the XRD patterns,
since in both cases the growth of HCA could be clearly detected.
Moreover, with regard to the Raman spectra, it is worth noting
that, after immersion in SBF, a new peak appeared at approximately
1070 cm−1, which is assigned to the carbonate group, thus conﬁrming
that the precipitated HA was indeed carbonated [52]. The comparison
between the spectra of the APS-HA coatings and the APS-HA/Fig. 9. Evolution of the XRD spectra of the APS-HA samples (bold trace) and of those of the
APS-HA/SPS-BG_Ca samples (thin trace) after in vitro tests. The spectra of the as-sprayed
samples are included as a term of comparison. Symbols: *, larnite (Ca2SiO4); ▲, TTCP; ▼,
TCP; ■, CaO;□, CaCO3; ●, HCA. The peaks without symbol are due to HA.
Fig. 10. Evolution of the Raman spectra of the APS-HA samples (bold trace) and of those of
the APS-HA/SPS-BG_Ca samples (thin trace) after in vitro tests. The spectra of the as-
sprayed samples are included as a term of comparison.SPS-BG_Ca (Fig. 10) shows that the peak at 1070 cm−1 is stronger
for the latter. Since the peak is strictly connected to the carbonate group
of the HCA grown in SBF, this discrepancy between the Raman spectra
further conﬁrms that the APS-HA/SPS-BG_Ca samples reacted in SBF
more quickly than the APS-HA ones.
Currently the discussion is still open on the real signiﬁcance of in vitro
tests. Indeed, the SBF (like other media, such as Hanks' balanced salt so-
lution HBSS, Na-lactate and lactic acid-buffered physiological solution
[53]) is simple salt solutions and, since it does not contain cells, it is not
able to reproduce the real complexity of a biological environment [54].
However it is generally recognized that SBF tests may be useful to evalu-
ate the ability to promote the growthof aHCA surface layer,which is sim-
ilar to themineral component of human bone [27]. So, even if the apatite
forming ability does not automatically imply the bone-bonding ability
[55], the development of a HCA layer in SBF may be still considered a
favourable indicator of the tendency to support the mineralization pro-
cess [27]. The results of the SBF tests therefore suggest that the addition
of a bioactive glass topcoat may be effective to improve the mineralizing
ability of a standard plasma sprayed HA coating, especially if the glass
topcoat possesses a ﬁne microstructure, with a controlled porosity.
4. Conclusions
In this study standard HA coatings with and without a functional
bioactive topcoat were produced and tested. In particular, the HA coat-
ings were sprayed through atmospheric plasma spray on stainless steel
substrates, while the glass topcoatwas produced via suspension plasma
spray.
117A. Cattini et al. / Surface & Coatings Technology 240 (2014) 110–117The bioactive glass topcoat showed high porosity and rough surface,
which constitute an optimum microstructure to promote bioactivity.
The coatings, with and without the glass topcoat, were tested in vitro
by immersion in a simulated body ﬂuid (SBF). It is interesting to observe
that the sampleswith the glass topcoat showed a greater reactivitywith
respect to pure HA coatings. In fact, both types of coatings were covered
by a calcium–phosphate layer after soaking in SBF, however the bioac-
tive glass topcoat was completely converted into hydroxy-carbonate-
apatite in less than one week. This phenomenon was conﬁrmed by
both ESEM investigation (with X-EDS microanalysis), and by X-ray
diffraction. Furthermore, the Raman analysis suggested that the HCA
developed on the bioactive glass topcoat exhibited a greater carbon-
ation level with respect to the layer that developed on pure HA.
Nevertheless, this is only a preliminary trial, since cell tests are
necessary to determine the biological effectiveness of the topcoat. In
this way it could be possible to verify whether the high porosity of the
topcoat, associated to the intrinsic bioactivity of the glass, could be
able to increase the absorption of metabolites and the cellular activity.
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